Alecensa Prescribing & Dosing Schedule | PrescriberPoint

Dosage & Administration Coverage Drug label Prior authorization Pharmacy Financial assistance Patient education People also ask

Alecensa(alectinib)

Alecensa 150 MG Oral Capsule

NO BOXED WARNING

Dosage & Administration

Dosage & Administration

600 mg orally twice daily. Administer ALECENSA with food.

Coverage Restrictions

Find Restrictions and Step Therapies for Alecensa

I don't know the employer

drug label

Alecensa Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

prior authorization

Alecensa Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jul 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jul 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jul 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jul 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jul 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jul 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jul 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jul 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jul 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jul 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Complete Letter of Medical Necessity

Coverage Authorization Appeals

Billing and Coding Guide

Benefits investigation

Prescriber Service & Patient Consent Form

Prescriber Service Form - Online Portal

Patient Consent Form

Patient Consent Form - Spanish

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

pharmacy

Alecensa Preferred Pharmacy

financial assistance

Alecensa Financial Assistance Options

Copay savings program

Prescriber Service & Patient Consent Form

Prescriber Service Form - Online Portal

Patient Consent Form

Patient Consent Form - Spanish

Enroll in Patient Savings Program

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

Prescriber Service & Patient Consent Form

Prescriber Service Form - Online Portal

Patient Consent Form

Patient Consent Form - Spanish

Alecensa Sure Start Program

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

Prescriber Service & Patient Consent Form

Prescriber Service Form - Online Portal

Patient Consent Form

Patient Consent Form - Spanish

Genentech Patient Foundation Application Form - Prescriber Form

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Alecensa Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

View How to Take Alecensa

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Doctor Discussion Guide

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Stories

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Real Talk about ALK+ mNSCLC

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Education Brochure - English

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Education Brochure - Spanish

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Education Brochure - Chinese

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

people also ask

Alecensa FAQs

Can ALECENSA be used during pregnancy?No, ALECENSA can cause fetal harm when administered to a pregnant woman. It is advised to avoid using ALECENSA during pregnancy and advise pregnant women of the potential risk to a fetus.

Can ALECENSA be used during lactation?No, there are no data on the presence of alectinib or its metabolites in human milk, the effects of alectinib on the breastfed infant, or its effects on milk production. It is advised to not breastfeed during treatment with ALECENSA and for 1 week after the final dose.

Should females and males of reproductive potential use contraception during treatment with ALECENSA?Yes, females of reproductive potential should use effective contraception during treatment with ALECENSA and for 1 week after the final dose. Males with female partners of reproductive potential should also use effective contraception during treatment with ALECENSA and for 3 months following the final dose.

Is ALECENSA safe for pediatric use?The safety and effectiveness of ALECENSA in pediatric patients have not been established.

Is ALECENSA safe for geriatric use?Clinical studies of ALECENSA did not include a sufficient number of subjects aged 65 and older to determine whether they respond differently from younger subjects.

Is ALECENSA safe for use in patients with renal or hepatic impairment?No dose adjustment is recommended for patients with mild or moderate renal impairment or mild (Child-Pugh A) or moderate (Child-Pugh B) hepatic impairment. However, the safety of ALECENSA in patients with severe renal impairment (creatinine clearance less than 30 mL/min) or end-stage renal disease and severe hepatic impairment (Child-Pugh C) is unknown.

FAQ Data Source